Impact of radiotherapy site, modality, and dose on subsequent clonal hematopoiesis

Authors

Alexander G Goglia, Memorial Sloan Kettering Cancer Center
Griffen R Mustion, Washington University School of Medicine in St. Louis
Leslie A Modlin, Memorial Sloan Kettering Cancer Center
Ross L Levine, Memorial Sloan Kettering Cancer Center
Kelly L Bolton, Washington University School of Medicine in St. Louis
Lior Z Braunstein, Memorial Sloan Kettering Cancer Center

Journal

Blood Advances

Publication Date

11-11-2025

Volume

9

Issue

21

First Page

5564

Last Page

5567

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2025016376

Rights and Permissions

Goglia AG, Mustion GR, Modlin LA, Levine RL, Bolton KL, Braunstein LZ. Impact of radiotherapy site, modality, and dose on subsequent clonal hematopoiesis. Blood Adv. 2025 Nov 11;9(21):5564-5567. doi: 10.1182/bloodadvances.2025016376. © 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Goglia, Alexander G; Mustion, Griffen R; Modlin, Leslie A; Levine, Ross L; Bolton, Kelly L; and Braunstein, Lior Z, "Impact of radiotherapy site, modality, and dose on subsequent clonal hematopoiesis." Blood Advances. 9, 21. 5564 - 5567. (2025).
https://digitalcommons.wustl.edu/oa_4/6415

Additional Links

Supplemental material is available for this article at publisher site.